Therma Bright Inc. (TBRIF)
USD 0.02
(-1.41%)
USD 0.02
(-1.41%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.62 Million CAD | -37.25% |
| 2022 | 5.89 Million CAD | -31.38% |
| 2021 | 8.59 Million CAD | 1300.52% |
| 2020 | 613.88 Thousand CAD | 49.83% |
| 2019 | 409.72 Thousand CAD | -67.23% |
| 2018 | 1.25 Million CAD | 25.46% |
| 2017 | 996.5 Thousand CAD | 373.75% |
| 2016 | 210.34 Thousand CAD | -40.22% |
| 2015 | 351.85 Thousand CAD | -20.2% |
| 2014 | 440.9 Thousand CAD | 38.75% |
| 2013 | 317.76 Thousand CAD | 21.1% |
| 2012 | 262.4 Thousand CAD | 35.52% |
| 2011 | 193.63 Thousand CAD | 0.0% |
| 2009 | 1.1 Million CAD | -16.18% |
| 2008 | 1.32 Million CAD | 0.77% |
| 2007 | 1.31 Million CAD | -37.34% |
| 2006 | 2.09 Million CAD | 77.07% |
| 2005 | 1.18 Million CAD | 65.86% |
| 2004 | 713.4 Thousand CAD | -23.43% |
| 2003 | 931.71 Thousand CAD | 3215.69% |
| 2002 | 28.1 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 142.12 Thousand CAD | -92.9% |
| 2024 Q2 | 93.26 Thousand CAD | -34.38% |
| 2024 Q3 | 300.35 Thousand CAD | 222.04% |
| 2023 Q2 | 683.85 Thousand CAD | 54.31% |
| 2023 Q1 | 443.17 Thousand CAD | -53.39% |
| 2023 Q4 | 2 Million CAD | 248.19% |
| 2023 FY | 3.7 Million CAD | -37.25% |
| 2023 Q3 | 574.61 Thousand CAD | -15.97% |
| 2022 Q3 | 1.08 Million CAD | -7.19% |
| 2022 Q2 | 1.16 Million CAD | -56.93% |
| 2022 Q1 | 2.7 Million CAD | 126.47% |
| 2022 FY | 5.89 Million CAD | -31.38% |
| 2022 Q4 | 950.76 Thousand CAD | -12.03% |
| 2021 Q4 | 1.19 Million CAD | -47.65% |
| 2021 Q3 | 2.28 Million CAD | 49.82% |
| 2021 Q1 | 3.6 Million CAD | 711.65% |
| 2021 Q2 | 1.52 Million CAD | -57.72% |
| 2021 FY | 8.59 Million CAD | 1300.52% |
| 2020 Q2 | 61.19 Thousand CAD | 2.52% |
| 2020 Q3 | 49.38 Thousand CAD | -19.3% |
| 2020 Q4 | 443.63 Thousand CAD | 798.4% |
| 2020 FY | 613.88 Thousand CAD | 49.83% |
| 2020 Q1 | 59.68 Thousand CAD | 118.52% |
| 2019 Q1 | 220.92 Thousand CAD | -59.54% |
| 2019 Q3 | 195.98 Thousand CAD | -37.81% |
| 2019 FY | 409.72 Thousand CAD | -67.23% |
| 2019 Q4 | -322.32 Thousand CAD | -264.47% |
| 2019 Q2 | 315.14 Thousand CAD | 42.65% |
| 2018 Q3 | 338.51 Thousand CAD | 204.28% |
| 2018 Q4 | 546.04 Thousand CAD | 61.3% |
| 2018 Q1 | 253.95 Thousand CAD | -61.26% |
| 2018 Q2 | 111.25 Thousand CAD | -56.19% |
| 2018 FY | 1.25 Million CAD | 25.46% |
| 2017 Q3 | 235.89 Thousand CAD | 279.31% |
| 2017 FY | 996.5 Thousand CAD | 373.75% |
| 2017 Q4 | 655.59 Thousand CAD | 177.92% |
| 2017 Q2 | 62.19 Thousand CAD | 45.21% |
| 2017 Q1 | 42.82 Thousand CAD | 93202.17% |
| 2016 Q1 | 120.15 Thousand CAD | 88.3% |
| 2016 FY | 210.34 Thousand CAD | -40.22% |
| 2016 Q4 | -46.00 CAD | -100.13% |
| 2016 Q3 | 36.8 Thousand CAD | -31.13% |
| 2016 Q2 | 53.43 Thousand CAD | -55.53% |
| 2015 Q4 | 63.81 Thousand CAD | -24.64% |
| 2015 FY | 351.85 Thousand CAD | -20.2% |
| 2015 Q1 | 86.24 Thousand CAD | -59.56% |
| 2015 Q2 | 117.13 Thousand CAD | 35.81% |
| 2015 Q3 | 84.67 Thousand CAD | -27.71% |
| 2014 Q2 | 69.01 Thousand CAD | -4.78% |
| 2014 Q1 | 72.47 Thousand CAD | -52.05% |
| 2014 FY | 440.9 Thousand CAD | 38.75% |
| 2014 Q4 | 213.25 Thousand CAD | 147.49% |
| 2014 Q3 | 86.16 Thousand CAD | 24.86% |
| 2013 Q1 | 54.73 Thousand CAD | -66.69% |
| 2013 FY | 317.76 Thousand CAD | 21.1% |
| 2013 Q4 | 151.15 Thousand CAD | 164.36% |
| 2013 Q3 | 57.17 Thousand CAD | 4.52% |
| 2013 Q2 | 54.7 Thousand CAD | -0.06% |
| 2012 Q1 | 38.63 Thousand CAD | 0.0% |
| 2012 Q2 | 32.39 Thousand CAD | -16.14% |
| 2012 FY | 262.4 Thousand CAD | 35.52% |
| 2012 Q4 | 164.34 Thousand CAD | 501.28% |
| 2012 Q3 | 27.33 Thousand CAD | -15.63% |
| 2011 FY | 193.63 Thousand CAD | 0.0% |
| 2010 Q3 | 48.04 Thousand CAD | -20.9% |
| 2010 Q2 | 60.74 Thousand CAD | 357200.0% |
| 2010 Q1 | 17.00 CAD | -100.0% |
| 2009 Q3 | 203.24 Thousand CAD | -29.78% |
| 2009 Q1 | 244 Thousand CAD | -19.73% |
| 2009 Q2 | 289.45 Thousand CAD | 18.63% |
| 2009 Q4 | 440.54 Thousand CAD | 116.75% |
| 2009 FY | 1.1 Million CAD | -16.18% |
| 2008 Q2 | 394.24 Thousand CAD | -9.78% |
| 2008 Q3 | 241.21 Thousand CAD | -38.82% |
| 2008 Q4 | 303.96 Thousand CAD | 26.01% |
| 2008 Q1 | 436.98 Thousand CAD | 17.88% |
| 2008 FY | 1.32 Million CAD | 0.77% |
| 2007 FY | 1.31 Million CAD | -37.34% |
| 2007 Q1 | 327.9 Thousand CAD | -49.84% |
| 2007 Q2 | 315.84 Thousand CAD | -3.68% |
| 2007 Q3 | 300.93 Thousand CAD | -4.72% |
| 2007 Q4 | 370.68 Thousand CAD | 23.18% |
| 2006 FY | 2.09 Million CAD | 77.07% |
| 2006 Q2 | 278.24 Thousand CAD | 11.65% |
| 2006 Q3 | 913.98 Thousand CAD | 228.48% |
| 2006 Q4 | 653.76 Thousand CAD | -28.47% |
| 2006 Q1 | 249.21 Thousand CAD | -18.73% |
| 2005 FY | 1.18 Million CAD | 65.86% |
| 2005 Q1 | 251.7 Thousand CAD | 0.0% |
| 2005 Q2 | 359.57 Thousand CAD | 42.86% |
| 2005 Q3 | 265.35 Thousand CAD | -26.2% |
| 2005 Q4 | 306.64 Thousand CAD | 15.56% |
| 2004 Q3 | 561.25 Thousand CAD | 221.13% |
| 2004 Q2 | 174.77 Thousand CAD | 25.48% |
| 2004 Q1 | 139.28 Thousand CAD | -31.36% |
| 2004 FY | 713.4 Thousand CAD | -23.43% |
| 2003 FY | 931.71 Thousand CAD | 3215.69% |
| 2003 Q2 | 171.43 Thousand CAD | -53.04% |
| 2003 Q1 | 365.08 Thousand CAD | 52.12% |
| 2003 Q4 | 202.91 Thousand CAD | 10.22% |
| 2003 Q3 | 184.1 Thousand CAD | 7.39% |
| 2002 Q2 | 121.2 Thousand CAD | 0.0% |
| 2002 Q3 | 205.41 Thousand CAD | 69.47% |
| 2002 Q4 | 240 Thousand CAD | 16.84% |
| 2002 FY | 28.1 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 703 Thousand USD | -415.937% |
| Össur hf. | 396.18 Million USD | 99.085% |
| QHSLab, Inc. | 961.65 Thousand USD | -277.167% |
| Wellstar International, Inc. | 1.79 Million USD | -102.097% |
| Össur hf. | 396.18 Million USD | 99.085% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.25 Million USD | 30.922% |
| Aurora Spine Corporation | 8.65 Million USD | 58.105% |
| BrainsWay Ltd. | 28.01 Million USD | 87.055% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 80.77 Million USD | 95.51% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 89.196% |
| BioElectronics Corporation | 740.67 Thousand USD | -389.692% |
| Vivos Inc. | 2.78 Million USD | -30.136% |
| Kelyniam Global, Inc. | 2.27 Million USD | -59.413% |
| Zecotek Photonics Inc. | 3.46 Million USD | -4.784% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -257.377% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 83.345% |
| Avitar, Inc. | 3.56 Million USD | -1.611% |
| Nanomix Corporation | 8.36 Million USD | 56.654% |
| Theraclion SA | 7.43 Million USD | 51.248% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -180.171% |
| NewCardio, Inc. | 9.56 Million USD | 62.078% |
| Positron Corporation | 1 Million USD | -260.08% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -16.608% |
| Lombard Medical, Inc. | 30.29 Million USD | 88.026% |
| ALR Technologies Inc. | 6.33 Million USD | 42.755% |
| Stratec SE | 46.32 Million USD | 92.17% |
| Vycor Medical, Inc. | 1.27 Million USD | -184.37% |
| Heart Tronics, Inc. | 14.46 Million USD | 74.917% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -2909.337% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.654% |
| VMS Rehab Systems, Inc. | 63.63 USD | -5700094.877% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -3.837% |
| Ingen Technologies, Inc. | 1.88 Million USD | -92.7% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -732.844% |
| Odyssey Group International, Inc. | -14.26 Million USD | 125.433% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 74.369% |
| IR-Med Inc. | 4.89 Million USD | 25.888% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1657.122% |
| United American Healthcare Corporation | 59 Thousand USD | -6047.515% |
| Polarean Imaging plc | 12.24 Million USD | 70.373% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -790.102% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -471.467% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -113.913% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -174.672% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -187.1% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 39.024% |
| SS Innovations International, Inc. | 21.38 Million USD | 83.037% |
| Urologix, Inc. | 10.09 Million USD | 64.06% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -1475.321% |
| Smith & Nephew plc | 3.46 Billion USD | 99.895% |
| NIOX Group Plc | 22.27 Million USD | 83.719% |
| Fuse Medical, Inc. | 10.35 Million USD | 64.956% |
| Broncus Holding Corporation | 38.15 Million USD | 90.493% |
| Brain Scientific Inc. | 9.66 Million USD | 62.464% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 64.796% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -5875.541% |